|
Volumn 136, Issue 12, 2000, Pages 1452-1458
|
Clinical features and contribution of virological findings to the management of Kaposi sarcoma in organ-allograft recipients
a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DOUBLE STRANDED DNA;
IMMUNOSUPPRESSIVE AGENT;
VIRUS ANTIBODY;
VIRUS DNA;
ADOLESCENT;
ADULT;
AGED;
ALLOTRANSPLANTATION;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER REGRESSION;
CLINICAL ARTICLE;
CLINICAL FEATURE;
FEMALE;
GRAFT SURVIVAL;
HUMAN;
HUMAN HERPESVIRUS 8;
IMMUNOFLUORESCENCE TEST;
IMMUNOSUPPRESSIVE TREATMENT;
KAPOSI SARCOMA;
MALE;
MONONUCLEAR CELL;
MORTALITY;
OPEN READING FRAME;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
VIRUS DETECTION;
VIRUS LOAD;
|
EID: 0034535909
PISSN: 0003987X
EISSN: None
Source Type: Journal
DOI: 10.1001/archderm.136.12.1452 Document Type: Article |
Times cited : (58)
|
References (28)
|